Pharma Journalist -

Following the FDA’s approval of 12 personalised medicines and 7 diagnostics in 2019, then a record number of precision oncology drugs in H1 2020, demand is high for Dx-enabled therapies…
Read More...

With the global oligonucleotide therapeutics market forecasted to climb to a record value of 7 billion dollars in the next 3 years, a rapidly increasing volume of FDA approvals and…
Read More...

AI Driven Drug Repositioning and Repurposing Summit taking place April 20-21, is an exciting online event which shines a light on the benefits of AI tools in drug repurposing and helps…
Read More...

Join our ground-breaking new conference dedicated to drive forward the development of effective therapies for chronic fibrosing ILDs. The ILD Summit takes place this April 27-29,…
Read More...

Cognate BioServices, Inc., the premier commercial-ready global CDMO in the Cell and Gene Therapy industry, and Nucleus Biologics, LLC, The Cell Performance Company, announced a…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines confirmed that the Company is in discussion with the U.S. government to purchase an…
Read More...

Ajinomoto Bio-Pharma Services  and Humanigen announced the companies will be expanding their manufacturing agreement for the fill finish supply of lenzilumab, which is one of the few…
Read More...

Eli Lilly and Company, Vir Biotechnology, Inc. and GlaxoSmithKline plc announced a collaboration to evaluate a combination of two COVID-19 therapies in low-risk patients with mild to…
Read More...

Care Access Research, a decentralized research organization (DRO) that operates as one connected team of physicians and research experts, announced a collaboration with global…
Read More...

Agenus Inc. an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and…
Read More...